Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

The Greater Cannabis Company, Inc. GCAN OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
11/100
0/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

The Greater Cannabis Company, Inc. (GCAN) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.21. It has a SharesGrow Score of 10/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Net income is $331,612 (loss), growing at -5%/yr. Net profit margin is 0% (thin). Gross margin is 0% (+0 pp trend).

Balance sheet: total debt is $0 against $0 equity. Current ratio is 0 (tight liquidity). Debt-to-assets is 0%. Total assets: $815.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 15/100 (Fail), Past 0/100 (Fail), Health 0/100 (Fail), Moat 28/100 (Fail), Future ?/100 (Fail), Income ?/100 (Fail).

GCAN SharesGrow Score Overview

22/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 15/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 0/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 28/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 0/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — GCAN

—
VALUE N/A
N/A
No analyst coverage available for this stock.
✗
GROWTH Fail
15/100
GCAN: +0%/yr revenue is, -5%/yr Net income is average growth. weak. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
—
HEALTH N/A
N/A
No analyst coverage available for this stock.
✗
MOAT Fail
28/100
GCAN: Gross margin is 0% (+0 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 28/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
—
INCOME N/A
N/A
No analyst coverage available for this stock.

Stock Chart & Stats

Market Data
52-Week Range0.036-3.6
Volume115
Avg Volume (30D)5.63K
Market Cap$188.15K
Beta (1Y)0.49
Share Statistics
Shares Outstanding$824.98M
IPO Date2018-09-18
Employees1
CEOAitan Zacharin
Financial Highlights & Ratios
EBITDA$-183.01K
Net Income$-331.61K
Operating Income$-183.01K
Total Cash$815.00
Net Debt$-815.00
Total Assets$815.00
Analyst Forecast
Company Info
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINUS3916572023

Price Chart

Track all markets on TradingView
GCAN
The Greater Cannabis Company, Inc. ↗  ·  Other OTC
Healthcare • Drug Manufacturers - Specialty & Generic
0.04 52WK RANGE 3.60

People Also View

MKKGY
MKKGY
MERCK Kommanditgesellschaft auf Aktien
$27.41
+2.47%
 MKGAF
MKGAF
MERCK Kommanditgesellschaft auf Aktien
$133.78
+3.43%
 CHNC
CHNC
China Infrastructure Construction Corp.
$0.00
+14.94%
 IGEX
IGEX
Indo Global Exchange(s) PTE, Ltd.
$0.00
+0.00%
 MGWFF
MGWFF
Maple Leaf Green World Inc.
$0.02
+0.00%
 GXXY
GXXY
Galexxy Holdings, Inc.
$0.00
+0.00%
 FTEG
FTEG
For The Earth Corp.
$0.00
+9,900.00%
 CSUI
CSUI
Cannabis Suisse Corp.
$0.01
+0.00%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message